Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
Protein Families02:47

Protein Families

17.2K
Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K
Protein Families02:47

Protein Families

4.5K
4.5K
Gene Families01:57

Gene Families

10.0K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.9K
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statewide Youth Vaping Prevention in West Virginia: Two-Year Outcomes of CATCH My Breath.

Journal of primary care & community health·2026
Same author

Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary Rehabilitation with Remote Therapeutic Monitoring.

International journal of chronic obstructive pulmonary disease·2025
Same author

A quasi-experimental analysis comparing antimicrobial usage on COVID-19 and non-COVID-19 wards.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2024
Same author

The CATCH My Breath Vaping Prevention Curriculum: An Evaluation of Impacts in Central Appalachian Middle and High Schools, 2019-2023.

Journal of primary care & community health·2024
Same author

Atypical presentation of right-sided native valve infective endocarditis.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2022
Same author

Antimicrobial Stewardship in Wound Care.

Advances in skin & wound care·2022

Related Experiment Video

Updated: Feb 16, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

8.4K

A Drug Regimen for Progressive Familial Cholestasis Type 2.

J Jeffrey Malatack1, Daniel Doyle2

  • 1Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware; and Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania jmalatac@nemours.org.

Pediatrics
|December 30, 2017
PubMed
Summary
This summary is machine-generated.

Progressive familial cholestasis type 2 (PFIC2) is a genetic liver disease. A novel multidrug regimen effectively managed symptoms in siblings with partial loss of bile salt export pump activity.

More Related Videos

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.5K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

8.4K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.5K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Area of Science:

  • Hepatology
  • Genetics
  • Pharmacology

Background:

  • Progressive familial cholestasis type 2 (PFIC2) results from genetic defects in the bile salt export pump (BSEP).
  • Reduced BSEP activity impairs bile salt excretion, causing hepatocyte damage and liver dysfunction.
  • Clinical signs include jaundice, severe pruritus, and progressive liver disease, with low serum gamma-glutamyl transpeptidase as a potential early indicator.

Observation:

  • This study reports on two siblings diagnosed with PFIC2 and partial loss of BSEP activity.
  • The siblings presented with classic clinical manifestations of the condition.

Findings:

  • A multidrug regimen comprising 4-phenylbutyrate, oxcarbazepine, and maralixibat was administered.
  • This therapeutic approach led to complete symptom control in both affected siblings.

Implications:

  • This combination therapy offers a potential new treatment strategy for PFIC2.
  • Further research into this regimen may provide alternatives to liver transplantation for select PFIC2 patients.